THIS SHARE WILL BE WORTH 3.00 IN 2009

bought back into pti after a 1yr gap. down app. 4%,pretty sure it will rebound. regard protherics as a well run, good quality pharma. happy to be in for the medium term.

Dissapointing performance since the rights issue - be carefull with this baby.
It does have the capacity to leave you high and dry.

Transco,

I paid 65p for my extra shares. The sp is now 71.75p. Considering consolidation how can you show they have performed badly.
Yes they have dipped from the highs of a couple of weeks ago but this is not an indication of a "capacity to leave you high and dry.
If you can expand on your statement please do so.

Greekman,

No offence just a few obsevations.

Point 1. They have underperformed the market. (I also purchased @ 65P.)
At at a time when other shares of this type have increased significantly.

Point 2. Track record on rights issues is not good I have held these for years and I have been involved in at least 2.

Point 3. I dont like pumping excercises like the one the IC did on these in December. It usually bodes ill.

Point 4. The company reports dont expect approval for anything until 2008 at the earliest.

Point 5. The company that bought a large stake are sitting on a huge profit and are likely to take some of it at some point.

Point 6. Press reports of drugs being overpriced.

Point 7. Any further delays in testing will see the SP drop sharply.

I could go on but its just my view and will continue to hold for the long term.

Transco,

No offence taken. I was just answering your comment "Dissapointing performance since the rights issue - be carefull with this baby.
It does have the capacity to leave you high and dry".

Can't see you have justified your comment. We will have to agree to disagree.

Cheers Greek

okay guys,thanks for clearing that one up for me!

Geekman,

No offence taken.

Transco - Parthus - Could be a long wait have patience!!!

What did I say???????????

i think you said have patience

True,

But dont be worried by jumping ship either. As I said...
This company has the capacity to dissapoint.

Purchases at the offer price dont look too good now do they?

Another 10 mill payment from AstraZeneca, due to the Scaling-up the CytoFab manufacturing process.
Now we can clearly see why the last placing was required. It does look like with this scaling up of manufacturing re CytoFab PTI are well on course.

All indications are that the management at PTI are putting it's cash pot to good use.

Now watch the institutions holdings increase, with hopefully new one's jumping on board.

Transco said a few posts ago...."It does have the capacity to leave you high and dry".

Still could...If my shares end up in about 3 to 5 years where I think they will, I may be high and dry on my own desert island, coconout palms, luxury boat, girls in grass skirts. Sorry Trans, could not resist.

OK, perhaps not but I can dream, can't I???

Nice one geekman but the pop today soon dried up.
The payments are no surprise and are all factored into the price.
I did read there was a contamination problem at their plant - I do hope its been resolved.
As for palm trees I hope I'm there with you but I have a nasty feeling about this one. The big boys are not on board yet I wonder why?

Still keep the faith!!

OK more sells than buys at the moment, but as the sp went up 3p on opening, many appear to be taking a profit, so I don't read too much into it.

I agree it was expected, but always nice to see, as things can and do go wrong,
There are always conditions involved re agreements like these trigger releases of cash, so nothing was set in stone.

Now real money in the bank.

It will be the sp at end of week, that will give a clearer indication of how the market views the latest bit of news.

shall i buy a lawnmower then?

Lawnmower?

Trans,

The lawn mower post was referring to my comment 0750hrs of the 12th, (girls in grass skirts). Bet you have been researching the full SEO website re a new product.

Looks like this is a push to increasing anti snake venom stock.
Can't do PTI any harm.

Fougera Marks Seventh Snakebite Season With CroFab Crotalidae Polyvalent Immune Fab (Ovine)
Urbanization and Climate Change Driving More Snakebites and New Strategies for Stocking Antivenom in 2007
MELVILLE, N.Y., March 13, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Fougera Inc. begins the 2007 snakebite season further ensuring adequate availability of CroFab(r) Crotalidae Polyvalent Immune Fab (Ovine), the only widely available antivenom for North American crotalid snakebite envenomations in the United States.

For Full article see link.....http://www.primenewswire.com/newsroom/news.html?d=115405

The anti venom product is small beer now.

We need FDA approval of the other stuff.......

SP continues to slide......... what did I say.

Transco,

Although now a small part of PTI, CroFab it is still a steady revenue earner.

As for SP continues to slide, I am sure you know as well as we do that it is totally down to the DOW, and is totally out of PTI's control.

stop bitching you two